Based on hybrid-capture method, the two panels cover the whole coding region of 468 and 324 cancer-related genes, respectively, and are capable of detecting selected fusions including NTRK1, NTRK2, and ETV6-NTRK3 (45, 46). The gene discussed is NTRK2; the disease is cancer.